Clinical Trials Sponsored by Wholesome Wave

Total 1511 results

Yale University
Hispanic Health Council, Inc.; Wholesome Wave

Recruiting

Feasibility and Impact of the FOOD4MOMS Produce Prescription Program Among Pregnant Latina Women (FOOD4MOMS)

Food Insecurity | Food Preferences | Food Selection

United States
Wholesome Wave
Yale-Griffin Prevention Research Center; One Community Health

Completed

Fruit and Vegetable Prescription in the Community Health Center Setting

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Poverty

United States
Icahn School of Medicine at Mount Sinai
New York Common Pantry; Corbin Hill Food Project; Wholesome Wave

Completed

Project Powerfood: Promoting Food Security, Equity, and Health

Obesity | Diabetes

United States
Wave Neuroscience

Completed

Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder

Depressive Disorder | Depression | Depressive Disorder, Major | Major Depressive Disorder | Depressive Episode

United States
Wave Neuroscience

Completed

A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

Autistic Disorder

United States
Wave Neuroscience

Completed

Synchronized Transcranial Magnetic Stimulation (sTMS) in Major Depressive Disorder (NEST-MDD)

Major Depressive Disorder

United States
Wave Neuroscience

Completed

Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD

Stress Disorders, Post-Traumatic

United States
Wave Neuroscience

Completed

A Randomized, Double-blind, Sham-controlled Pilot Study to Evaluate the Treatment Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) in College Students With ADHD (MeRT-USC-009)

ADHD

United States
Wave Neuroscience

Completed

A Chart Review to Evaluate the Safety and Efficacy of MeRT on Subjects With ASD

Autistic Disorder

United States
Wave Neuroscience

Recruiting

EEG Personalized Transcranial Magnetic Stimulation (eTMS) for Post-Traumatic Stress Disorder

Stress Disorders, Post-Traumatic

United States
Spine Wave

Completed

Annex™ Adjacent Level System for Treatment of Adjacent Level Disease

Degenerative Disc Disease | Adjacent Level Disease

United States
Wave Neuroscience

Completed

Feasibility Study to Test Clinical Efficacy of Low Energy AC Magnetic Field to Treat Major Depression

Major Depressive Disorder (MDD)

United States, China
Spine Wave

Terminated

Clinical Evaluation of GENEX® DS in Instrumented Posterolateral Fusion

Degenerative Disc Disease | Spondylolisthesis | Stenosis

United States
Wave Neuroscience

Completed

A Trial To Evaluate The Efficacy of Magnetic Resonant Therapy in Autism

Autism Spectrum Disorder

United States
Third Wave Therapeutics

Recruiting

Sounds for Sleep Study in Patients Suffering From Moderate to Severe Insomnia

Insomnia

United States
V-Wave Ltd

Recruiting

Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH) (RELIEVE-PAH)

Pulmonary Arterial Hypertension

United States, Canada, Mexico
V-Wave Ltd

Active, not recruiting

Reducing Lung CongestIon Symptoms in Advanced Heart Failure (RELIEVE-HF)

Heart Failure

United States, Israel, Spain, Germany, New Zealand, Canada, Australia, Switzerland, Belgium, Netherlands, Poland
Third Wave Therapeutics

Completed

A User Study of the Soniflow System for Nasal Congestion Relief

Nasal Congestion

United States
Third Wave Therapeutics

Completed

Sonu Nasal Congestion Relief Study in Patients Suffering From Moderate to Severe Nasal Congestion (SCORE)

Nasal Congestion and Inflammations

United States
V-Wave Ltd

Completed

The V-Wave Shunt: FIM Safety and Feasibility Study (VW-SP-1)

Congestive Heart Failure

Spain, Germany, Israel
Third Wave Therapeutics

Recruiting

Sonu Real-World Use Clinical Study to Treat Moderate to Severe Nasal Congestion

Nasal Congestion

United States
V-Wave Ltd

Withdrawn

Heart Failure (HF) Interatrial Shunt Study 1

Chronic Heart Failure

Israel
Wave Life Sciences Ltd.

Recruiting

Study of WVE-003 in Patients With Huntington's Disease

Huntington Disease

Canada, Spain, Australia, Denmark, Netherlands, Poland, United Kingdom, France, Germany, Italy
First Wave BioPharma, Inc.

Active, not recruiting

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection (RESERVOIR)

Covid19

United States, Ukraine, India
First Wave Bio, Inc.

Completed

OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis

Cystic Fibrosis (CF) | Exocrine Pancreatic Insufficiency (EPI)

United States, Poland
First Wave Bio, Inc.

Completed

OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis (OPTION)

Cystic Fibrosis (CF) | Exocrine Pancreatic Insufficiency (EPI)

United States, Poland
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease (PRECISION-HD2)

Huntington's Disease

United States, Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy (DYSTANCE 51)

Duchenne Muscular Dystrophy

United States, Belgium, United Kingdom, Czechia, Canada, France, Italy, Sweden
Wave Life Sciences Ltd.

Recruiting

A Phase 1 Research Study to Evaluate Safety, Tolerability, and Pharmacokinetics of WVE-006 in Healthy Participants With Wild-type AAT Expression (RestorAATion-1) (RestorAATion-1)

Alpha-1 Antitrypsin Deficiency

United Kingdom
First Wave BioPharma, Inc.

Completed

Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis (SPAN)

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Wave Life Sciences Ltd.

Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

ALS | FTD

Netherlands, United Kingdom
First Wave Bio, Inc.

Withdrawn

Niclosamide In Moderate COVID-19

COVID
First Wave Bio, Inc.

Withdrawn

Niclosamide in COVID-19

Covid19
Wave Life Sciences Ltd.

Terminated

Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease (PRECISION-HD1)

Huntington's Disease

Denmark, Canada, Australia, United Kingdom, France, Germany, Poland
Wave Life Sciences Ltd.

Terminated

Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Huntington Disease

Denmark, Australia, Canada, France, United Kingdom, Germany, Poland
Wave Life Sciences Ltd.

Completed

Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy

Duchenne Muscular Dystrophy

Belgium, United Kingdom, France, United States, Italy, Canada, Netherlands
Wave Life Sciences Ltd.

Active, not recruiting

Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Duchenne Muscular Dystrophy

Jordan, United Kingdom
Wave Life Sciences Ltd.

Terminated

Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) (FOCUS-C9)

ALS | FTD

Canada, Belgium, New Zealand, Netherlands, Australia, Sweden, United Kingdom, Ireland
First Wave Bio, Inc.

Terminated

A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis

Ulcerative Colitis | Ulcerative Proctitis | Ulcerative Proctosigmoiditis

Italy
Sound Wave Innovation CO., LTD.

Recruiting

A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease

Alzheimer Disease, Early Onset

Japan
Providence VA Medical Center
Wave Neuroscience

Completed

Synchronized Transcranial Magnetic Stimulation for PTSD (sTMS)

Depression | PTSD

United States
Wake Forest University

Recruiting

Muscle Fiber Fragment Treatment for Urinary Incontinence

Urinary Incontinence

United States
Wake Forest University

Completed

Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema

Uveitis | Cystoid Macular Edema

United States
Wake Forest University Health Sciences
Wake Forest University

Completed

Weight Loss With Risedronate for Bone Health (WERISE)

Weight Loss | Bone Loss | Bariatric Surgery Candidate

United States
Wake Forest University

Completed

Using an Internet Study to Improve Adherence for Psoriasis Patients

Psoriasis

United States
Wake Forest University

Completed

Mild Cognitive Impairment, Buddy Supported Exercise/ My Buddy Study

Mild Cognitive Impairment | Cognitive Disorders

United States
Wake Forest University

Completed

Rehabilitation and Exercise Training After Hospitalization (REHAB-HF)

Heart Failure

United States
Wake Forest University

Terminated

Direct Noise Reduction in the Intensive Care Units (ICU) Using Earplugs and Noise Canceling Headphones

Delirium | Sleep Fragmentation

United States
Wake Forest University

Completed

Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States

Clinical Trials Sponsored by Wholesome Wave

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations